CClinicalTrials.gg
CompletedNCT07252063Updated May 26, 2026

Sensory Distribution and Postoperative Analgesia of Ultrasound-Guided Interfascial Plane Blocks in Living Liver Donors

An observational study in Pain, sponsored by Bahçeşehir University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-26.

Sponsored by Bahçeşehir University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Living liver donor hepatectomy at our institution routinely includes ultrasound-guided interfascial plane blocks as part of postoperative analgesia. Although these blocks have become increasingly used in donor hepatectomy, their cutaneous sensory distributions and block-related dermatomal coverage have not been systematically evaluated, with only anecdotal reports available in the literature.

This prospective observational study aims to assess both the sensory blockade patterns and the early postoperative analgesic performance of interfascial plane blocks administered to living liver donors. Following surgery, all consenting donors receive the institution's standard block protocol. Cutaneous sensory mapping is performed in the post-anesthesia care unit (PACU) at the second postoperative hour. Pain intensity and analgesic requirements within the first 24 hours are also recorded.

The study is designed to provide objective data on the dermatomal coverage and postoperative analgesic effects of contemporary ultrasound-guided interfascial plane blocks used in living liver donor surgery.

02

Conditions studied

  • Pain

Browse trials for

03

In context

Pain

2,219 studies on the registry are indexed under Pain; 917 are open to participants now.

This study's enrollment of 30 is below the median of 107 across 270 observational studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Bahçeşehir University is the lead sponsor of 117 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population consists of adult living liver donors undergoing elective donor hepatectomy at a tertiary care center. All participants receive ultrasound-guided interfascial plane blocks as part of the institution's routine postoperative analgesia protocol. Eligible donors are aged 18 to 65 years, classified as ASA physical status I-II, and able to cooperate with postoperative cutaneous sensory mapping procedures. Individuals with contraindications to regional anesthesia, conditions preventing accurate sensory assessment, or those who decline participation are excluded.

Inclusion criteria

  • Adult living liver donors undergoing elective donor hepatectomy
  • Age 18 to 65 years
  • ASA physical status I-II
  • Patients who have received ultrasound-guided interfascial plane blocks as part of their postoperative analgesia
  • Ability to cooperate with postoperative sensory mapping procedures
  • Patients who agree to participate and provide written informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients who refuse to participate or do not provide written informed consent
  • Patients who have not received any ultrasound-guided interfascial plane block
  • ASA physical status > II
  • Presence of surgical incisions or wound complications preventing reliable sensory mapping
  • Prior major abdominal surgery that may alter cutaneous innervation patterns
  • Cognitive impairment limiting the ability to cooperate with sensory testing
  • Known psychiatric disorders (e.g., major depression, mania, schizophrenia) that may interfere with postoperative assessment
  • Local infection, skin disease, or dermatologic condition preventing accurate cutaneous mapping
  • Allergy or contraindication to local anesthetics used in the block
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No

Interventions

  • Otherinterfascial plane block

    Ultrasound-guided interfascial plane blocks are administered at the end of surgery. Block selection and needle entry points are determined according to the surgical incision line and the location of abdominal drains. All blocks are performed under real-time ultrasound guidance using the institution's standardized protocol.

  • Otherpatient controlled analgesia device

    Intravenous patient-controlled analgesia is initiated in the postoperative period according to the institution's standard protocol. PCA settings, opioid type, basal infusion (if applicable), and bolus doses follow routine clinical practice and are recorded for analysis. PCA use during the first 24 hours is monitored to assess postoperative analgesic requirements.

  • Othercutaneus sensory mapping

    Cutaneous sensory mapping is performed in the post-anesthesia care unit (PACU) at the second postoperative hour. Sensory blockade is assessed using a standardized pinprick test applied radially from medial to lateral directions. The borders of the blocked and unblocked regions are marked on the skin using a UV-visible dermatographic pen. Mapping is conducted over the mid-abdominal and lateral abdominal regions, and the total cutaneous coverage areas are subsequently calculated for analysis.

06

What researchers measure

Primary outcomes

  1. Cutaneous sensory block area mapping for different regional anesthesia techniques in liver donor surgery

    The cutaneous sensory block area produced by the regional anesthesia technique will be evaluated at the 120th minute post-block using a standardized pinprick test. Sensory borders will be identified radially and marked on the skin with a UV-visible marker. Each mapped region will be photographed with a calibrated reference scale placed on the skin. These images will be processed using a predefined digital template to calculate the total blocked surface area in square centimeters. The resulting measurements will be used to characterize the sensory distribution of the interfascial plane blocks in living liver donors.

    Time frame: At 120 minutes after block administration in the post-anesthesia care unit (PACU).

07

Study locations

1 site
  • Bahcesehir Unişversity Medicalpark Goztepe hospital
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07252063
Lead sponsor
Bahçeşehir University
Responsible party
Selma Basyigit (Department of Anesthesiology, Bahçeşehir University) — Principal investigator
First posted
Nov 26, 2025
Start date
Nov 1, 2025
Primary completion
May 21, 2026
Completion
May 21, 2026
Last update
May 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion